INS and lung carcinoma: For instance, some studies found no association between antidiabetic drugs and the risk of lung cancer (50), while others suggested a possible increased risk of insulin use (51), decreased risk with pioglitazone (52), and no significant association with lung cancer for pioglitazone (53).